Norden Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Sell |
543
-38
| -7% | -$20K | 0.03% | 456 |
|
|
2025
Q1 | $368K | Buy |
581
+81
| +16% | +$51.4K | 0.04% | 378 |
|
|
2024
Q4 | $356K | Sell |
500
-159
| -24% | -$113K | 0.04% | 381 |
|
|
2024
Q3 | $693K | Buy |
659
+244
| +59% | +$257K | 0.08% | 265 |
|
|
2024
Q2 | $436K | Buy |
415
+27
| +7% | +$28.4K | 0.09% | 239 |
|
|
2024
Q1 | $373K | Buy |
388
+126
| +48% | +$121K | 0.08% | 289 |
|
|
2023
Q4 | $230K | Buy |
+262
| New | +$230K | 0.04% | 240 |
|